Form 4 for TRVI Trevi Therapeutics, Inc.
Accepted 2024-05-14 00:00:00 ET · period of report 2024-05-10 · accession 0000950170-24-059722 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-05-14 | 2024-05-10 | TRVI | GOOD JENNIFER L | Pres, CEO, Dir | S - Sale+OE | $2.90 | -4,578 | 213.3K | -2% | -$13.3K |
| D | 2024-05-14 | 2024-05-10 | TRVI | GOOD JENNIFER L | Pres, CEO, Dir | M - OptEx | $2.19 | +4,578 | 217.9K | +2% | +$10.0K |
| D | 2024-05-14 | 2024-05-10 | TRVI | GOOD JENNIFER L | Pres, CEO, Dir | M - OptEx | $0.00 | -4,578 | 58.2K | -7% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-10 | S | D | 4,578 | $2.90 | 213,313 | D | — | — | (F1) Includes 7,109 shares purchased through the Issuer's employee stock purchase plan. |
| 2 | Common | Common Stock | 2024-05-10 | M | A | 4,578 | $2.19 | 217,891 | D | — | — | (F1) Includes 7,109 shares purchased through the Issuer's employee stock purchase plan. |
| 3 | Derivative | Stock Option (right to buy) | 2024-05-10 | M | D | 4,578 | $0.00 | 58,226 | D | $2.19 · — to 2024-07-01 | 4,578 Common Stock | (F2) This option was granted on July 2, 2014. The 62,804 shares of common stock underlying the option vested as to 25% of the shares on June 11, 2015 and vested as to the remaining 75% of the shares in equal monthly installments thereafter through June 11, 2018. |